AAIC26: Cognito sheds light on biological underpinnings of Alzheimer’s headset

Cognito, a neuromodulation headset for Alzheimer's disease, showed biological effects in a presentation at AAIC26. The device increased cerebrospinal fluid levels of HDL-like lipid transport proteins, indicating a coordinated biological response to the therapy. The finding provides mechanistic evidence for how the headset may work at a cellular level.